0.4544USD-7.27%Mkt Cap: 28.53M USDP/E: —Last update: 2026-06-01
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship pro…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap28.53M USD
Enterprise Value55.29M USD
Revenue (TTM)37.20M USD
Gross Profit26.49M USD
Net Income (TTM)-8.20M USD
Revenue/Share0.5930 USD
Last Price0.4544 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees129
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS23283X2062
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-4.64
EV/Revenue1.49
P/S0.83
P/B14.03
EPS (TTM)-0.19
EPS (Forward)0.00
52W Range
0.43502% of range1.390
52W High1.390 USD
52W Low0.4350 USD
Profitability
Gross Margin71.48%
Oper. Margin-34.34%
EBITDA Margin-32.04%
Profit Margin-22.12%
ROE-138.88%
ROA-18.56%
Growth
Revenue Growth1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.38M USD
CapEx (TTM)491.00K USD
FCF Margin-12.58%
FCF Yield-16.40%
Net Debt24.46M USD
Net Debt/EBITDA-2.05
Balance Sheet
Debt/Equity4.93
Current Ratio1.09
Quick Ratio0.73
Book Value/Sh0.0350 USD
Cash/Share0.0770 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateDec 5, 2014
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)2.875 USD
Target Range0.7500 USD – 5.000 USD
# Analysts2
Ownership
Shares Out.62.79M
Float55.09M
Insiders14.85%
Institutions26.41%
Short Interest
Short Ratio29.2d
Short % Float3.38%
Short % Out.3.28%
Shares Short2.06M
Short (prev mo.)2.04M
Technical
SMA 500.5878 (-22.7%)
SMA 2000.7388 (-38.5%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)80.65K
Avg Vol (10d)144.06K
Technical Indicators
RSI (14)37.8
MACD-0.0382
MACD Signal-0.0356
MACD Hist.-0.0026
BB Upper0.6652 USD
BB Middle0.5361 USD
BB Lower0.4070 USD
BB Width48.17%
ATR (14)0.0460 USD
Vol Ratio (20d)0.60x